Byrne JC - Search Results

1

Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, Watson RW. Downes MR, et al. Among authors: byrne jc. BJU Int. 2007 Feb;99(2):263-8. doi: 10.1111/j.1464-410X.2006.06610.x. Epub 2006 Dec 1. BJU Int. 2007. PMID: 17092277 Review.

2

Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.

Girard FP, Byrne J, Downes M, Fanning D, Desgrandchamps F, Fitzpatrick JM, Watson RW. Girard FP, et al. Neoplasma. 2010;57(5):488-93. doi: 10.4149/neo_2010_05_488. Neoplasma. 2010. PMID: 20568904

3

Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.

Fan Y, Murphy TB, Byrne JC, Brennan L, Fitzpatrick JM, Watson RW. Fan Y, et al. Among authors: byrne jc. J Proteome Res. 2011 Mar 4;10(3):1361-73. doi: 10.1021/pr1011069. Epub 2011 Jan 27. J Proteome Res. 2011. PMID: 21166384

4

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.

Downes MR, Byrne JC, Dunn MJ, Fitzpatrick JM, Watson RW, Pennington SR. Downes MR, et al. Among authors: byrne jc. Biomarkers. 2006 Sep-Oct;11(5):406-16. doi: 10.1080/13547500600799821. Biomarkers. 2006. PMID: 16966158 Review.

5

Fasting status as a consideration for human serum collection and preparation prior to depletion and analysis.

Byrne JC, Downes MR, O'Donoghue N, Fitzpatrick JM, Dunn MJ, Watson RW. Byrne JC, et al. Electrophoresis. 2008 Jul;29(14):3055-9. doi: 10.1002/elps.200700933. Electrophoresis. 2008. PMID: 18551713

6

2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.

Byrne JC, Downes MR, O'Donoghue N, O'Keane C, O'Neill A, Fan Y, Fitzpatrick JM, Dunn M, Watson RW. Byrne JC, et al. J Proteome Res. 2009 Feb;8(2):942-57. doi: 10.1021/pr800570s. J Proteome Res. 2009. PMID: 19093873

7

Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure.

Watson CJ, Ledwidge MT, Phelan D, Collier P, Byrne JC, Dunn MJ, McDonald KM, Baugh JA. Watson CJ, et al. Among authors: byrne jc. Circ Heart Fail. 2011 Mar;4(2):188-97. doi: 10.1161/CIRCHEARTFAILURE.110.952200. Epub 2011 Jan 31. Circ Heart Fail. 2011. PMID: 21282491

8

Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.

Bones J, Byrne JC, O'Donoghue N, McManus C, Scaife C, Boissin H, Nastase A, Rudd PM. Bones J, et al. Among authors: byrne jc. J Proteome Res. 2011 Mar 4;10(3):1246-65. doi: 10.1021/pr101036b. Epub 2011 Jan 19. J Proteome Res. 2011. PMID: 21142185

9

IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia.

Coss KP, Byrne JC, Coman DJ, Adamczyk B, Abrahams JL, Saldova R, Brown AY, Walsh O, Hendroff U, Carolan C, Rudd PM, Treacy EP. Coss KP, et al. Among authors: byrne jc. Mol Genet Metab. 2012 Feb;105(2):212-20. doi: 10.1016/j.ymgme.2011.10.018. Epub 2011 Nov 7. Mol Genet Metab. 2012. PMID: 22133299

10

Galactosemia, a single gene disorder with epigenetic consequences.

Coman DJ, Murray DW, Byrne JC, Rudd PM, Bagaglia PM, Doran PD, Treacy EP. Coman DJ, et al. Among authors: byrne jc. Pediatr Res. 2010 Mar;67(3):286-92. doi: 10.1203/PDR.0b013e3181cbd542. Pediatr Res. 2010. PMID: 19952866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page